Bentham期刊
期刊
会议
图书
作者:Wang Chun Kwok , James Chung Man Ho , David Chi Leung Lam ...
来源:[J].Clinical Cancer Drugs, 2020, Vol.7 (1), pp.57-61
摘要:Background: Gefitinib was approved by the Food and Drug Administration (FDA of the United States (US for treatment of advanced non-small cell carcinoma harboring sensitizing epidermal growth factor receptor (EGFR mutations. Gastric acid suppressing medication use inhibits gefitin...
作者:Hemantkumar Patadia , Ankita Priyadarshini , Jay Ranade ...
来源:[J].Clinical Cancer Drugs, 2020, Vol.7 (1), pp.25-43
摘要:Background: Breast Cancer is a recurrent problem across the world. According to a report, breast cancer has the second highest mortality rate in women globally. Despite having an advanced degree of chemotherapy, resistance is developed against the therapies. Studies showed that a...
作者:Reena Kasi , Pei Ling Yeo , Ng. Khuen Yen ...
来源:[J].Clinical Cancer Drugs, 2020, Vol.7 (1), pp.44-56
摘要:Background: Recent human and animal studies have demonstrated the oncostatic properties of N-acetyl-5-methoxytryptamine (melatonin in different types of cancer. However, in few cancer cell lines including colorectal cancer cell line (HT-29, acute T cell leukemia cell line (J...
作者:Neslisah Barlak , Fatma Sanli , Ozel Capik ...
来源:[J].Clinical Cancer Drugs, 2020, Vol.7 (1), pp.16-24
摘要:Background: Larynx cancer (LCa is the most common head and neck cancer and accounts for 1-2.5% of all human cancers worldwide. Metformin, an oral anti-diabetic drug, has been recently shown to have anti-cancer activity in various cancer types, and there are several studies in the...
作者:Gang Yuan , Lishi Wang , Jing Li ...
来源:[J].Clinical Cancer Drugs, 2020, Vol.7 (1), pp.3-15
摘要:More than 90% of new potential therapeutic drugs have failed in clinical trials. In this study, the characteristics of failed new drugs for the treatment of seven types of cancer were first examined, followed by a review of the hazard ratios of survival in typical phase III ...
作者:Krishnasamy Gopinath , Nagarajan Subbiah , Muthusamy Karthikeyan
来源:[J].The Natural Products Journal, 2020, Vol.10 (2), pp.168-176
摘要:Background: Syzygium densiflorum Wall. ex Wight & Arn (Myrtaceae has been traditionally used by the local tribes of the Nilgiris, Tamil Nadu, India, for the treatment of diabetes. Objective: This study aimed to isolate the major phytoconstituents from the S. densiflorum frui...
作者:Yoshiyuki Kimura
来源:[J].The Natural Products Journal, 2020, Vol.10 (2), pp.177-185
摘要:Background: The cortex of Mallotus japonicus (Euphorbiaceae has traditionally been used to treat gastric ulcers, duodenal ulcers, and gastric hyperacidity in Japan. A large number of studies have recently focused on its effects on inflammatory bowel disease (IBD. Objective: ...
作者:Haoyu Lv , Yabin Tang , Fan Sun ...
来源:[J].The Natural Products Journal, 2020, Vol.10 (2), pp.122-129
摘要:Background: In recent years, more and more researches have shown that neurotransmitters can also be synthesized and released by peripheral non-neural cells. However, specificity and high sensitivity detection means were required for confirming ESCs autocrine glutamate and γ-...
作者:Folorunso Adewale Olabiyi , Yapo Guillaume Aboua , Olugbenga Kayode Popoola ...
来源:[J].The Natural Products Journal, 2020, Vol.10 (2), pp.130-138
摘要:Background: Antioxidant and antityrosinase activities of medicinal plants, together with their various health benefits have received attention in recent times. However, with wide ethnobotanical uses of Phyllanthus amarus, data on in-vitro skin depigmentation activity and cyt...
作者:Humaira Yasmeen Gondal , Roshan Zamir , Muhammad Nisar ...
来源:[J].The Natural Products Journal, 2020, Vol.10 (2), pp.158-162
摘要:Background: The genus Verbascum is well documented for its antioxidant potential but Verbascum sinaiticum is comparatively less studied plant. The current study was carried out to search for antioxidant nutraceuticals from this species. Objective: To explore the antioxidant poten...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×